13F filer · CIK 1513038 ↗
Perkins Coie Trust Co
You are looking at Q3 2017. See the latest, Q3 2026 →
Reported value
$192.6M
+3.6% on the quarter before
Positions
330
6 new · 7 sold out
Top 10
30.5%
of the value
Est. gain
+$6.8M
on stocks held all quarter
Est. return
+3.7%
on those stocks since Q2 2017
Positions as of Sep 30, 2017, from Perkins Coie Trust Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 51% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.
Largest buys
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Baker Hughes~$611,000New · 0.0% → 0.3%+16,688 shares
- Bb&T Corp~$495,447Added · 0.8% → 1.0%+10,560 shares
- Metlife Inc~$384,318Added · 1.0% → 1.1%+7,397 shares
- Brighthouse Financial Inc~$227,000New · 0.0% → 0.1%+3,730 shares
- Dowdupont Inc~$173,000New · 0.0% → 0.1%+2,503 shares
- AT&T~$74,141Added · 1.3% → 1.3%+1,893 shares
- Walt Disney Company (The)~$63,783Added · 1.6% → 1.4%+647 shares
- BlackRock~$60,808Added · 1.3% → 1.3%+136 shares
- Intel~$60,451Added · 1.1% → 1.2%+1,588 shares
- Exxon Mobil Corp~$57,125Added · 0.4% → 0.4%+697 shares
Largest sells
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Baker Hughes Inc~$884,000Sold out · 0.5% → 0.0%−16,224 shares
- Unitedhealth Group Inc~$448,309Cut · 1.8% → 1.6%−2,289 shares
- Ishares S&P 500 Growth~$344,491Cut · 7.6% → 7.5%−2,402 shares
- Utilities Select Sector SPDR ETF~$340,262Cut · 1.3% → 1.1%−6,415 shares
- Microsoft~$207,391Cut · 3.7% → 3.7%−2,784 shares
- Ishares S&P Midcap 400 Growth~$160,272Cut · 4.6% → 4.5%−792 shares
- Dow Chemical Co~$120,000Sold out · 0.1% → 0.0%−1,906 shares
- Boeing Co~$112,345Cut · 0.6% → 0.6%−442 shares
- Du Pont (Ei) De Nemours~$97,000Sold out · 0.1% → 0.0%−1,196 shares
- Whole Foods Market Inc~$86,000Sold out · 0.0% → 0.0%−2,050 shares
Holdings
As of Sep 30, 2017. Changes are in shares against Jun 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ishares S&P 500 GrowthEQUITY - LARGE CAP - ETF · shares −2.3% · price +4.8% | 7.5% | $14.5M | +$663,714 | ||||||||
| Ishares S&P Midcap 400 GrowthEQUITY - MIDCAP - ETF · shares −1.8% · price +2.9% | 4.5% | $8.7M | +$247,717 | ||||||||
| MicrosoftCOMMON STOCK · shares −2.8% · price +8.1% | 3.7% | $7.1M | +$532,908 | ||||||||
| 3m CoCOMMON STOCK · shares −0.3% · price +0.8% | 3.3% | $6.3M | +$51,656 | ||||||||
| Graco Inc.COMMON STOCK · shares 0% · price +13.2% | 2.2% | $4.3M | +$498,000 | ||||||||
| AppleCOMMON STOCK · shares −0.4% · price +7.0% | 2.1% | $4.1M | +$270,276 | ||||||||
| Vanguard S&P 500 ETFEQUITY - LARGE CAP - ETF · shares 0% · price +3.9% | 1.9% | $3.6M | +$135,000 | ||||||||
| Procter & Gamble CoCOMMON STOCK · shares +0.6% · price +4.4% | 1.8% | $3.5M | +$145,259 | ||||||||
| Home Depot IncCOMMON STOCK · shares 0% · price +6.6% | 1.8% | $3.4M | +$210,000 | ||||||||
| SPDR S&P Biotech ETFEQUITY SECTOR - ETF · shares −2.0% · price +12.2% | 1.7% | $3.3M | +$353,734 | ||||||||
| Pepsico IncCOMMON STOCK · shares +1.3% · price −3.5% | 1.6% | $3.1M | −$111,675 | ||||||||
| Pnc Financial Services GroupCOMMON STOCK · shares +0.8% · price +7.9% | 1.6% | $3.1M | +$222,823 | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −13% · price +5.6% | 1.6% | $3.0M | +$162,379 | ||||||||
| Chevron CorpCOMMON STOCK · shares +1.8% · price +12.6% | 1.5% | $2.9M | +$318,243 | ||||||||
| Wells Fargo & CoCOMMON STOCK · shares +0.7% · price −0.4% | 1.5% | $2.9M | −$12,806 | ||||||||
| CiscoCOMMON STOCK · shares +1.7% · price +7.5% | 1.5% | $2.8M | +$193,727 | ||||||||
| Walt Disney Company (The)COMMON STOCK · shares +2.4% · price −7.2% | 1.4% | $2.8M | −$209,783 | ||||||||
| Visa Inc.COMMON STOCK · shares +1.3% · price +12.2% | 1.4% | $2.7M | +$291,851 | ||||||||
| Ishares S&P Midcap 400 GrowthEQUITY - MIDCAP - ETF · shares 0% · price +2.9% | 1.4% | $2.7M | +$76,000 | ||||||||
| OracleCOMMON STOCK · shares +0.8% · price −3.6% | 1.4% | $2.6M | −$96,886 | ||||||||
| Stryker CorpCOMMON STOCK · shares +0.07% · price +2.3% | 1.4% | $2.6M | +$60,154 | ||||||||
| Comcast CorpCOMMON STOCK · shares +0.6% · price −1.1% | 1.3% | $2.6M | −$29,617 | ||||||||
| Pfizer IncCOMMON STOCK · shares +2.0% · price +6.3% | 1.3% | $2.6M | +$149,735 | ||||||||
| BlackRockCOMMON STOCK · shares +2.4% · price +5.8% | 1.3% | $2.5M | +$137,192 | ||||||||
| AT&TCOMMON STOCK · shares +3.0% · price +3.8% | 1.3% | $2.5M | +$89,859 | ||||||||
| Total · 330 positions | 100% | $192.6M | +$6.8M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2017 to Q3 2017: 322 stocks held throughout, up $6.8M (+3.7%).
- Ishares S&P 500 Growth+$663,714+5%
- Microsoft+$532,908+8%
- Graco Inc.+$498,000+13%
- Abbvie Inc+$391,934+23%
- SPDR S&P Biotech ETF+$353,734+12%
- Qualcomm−$117,383−6%
- IBM−$131,398−6%
- General Electric Co−$148,474−10%
- Walt Disney Company (The)−$209,783−7%
- Medtronic Plc−$298,842−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 14, 2026 | $625.7M+4% | SEC ↗ |
| Q2 2026 | Jul 9, 2026 | $603.3M+16% | SEC ↗ |
| Q1 2026 | Apr 15, 2026 | $520.1M−3% | SEC ↗ |
| Q4 2025 | Jan 12, 2026 | $537.0M+1% | SEC ↗ |
| Q3 2025 | Oct 9, 2025 | $531.5M−9% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $587.1M+33% | SEC ↗ |
| Q1 2025 | Apr 11, 2025 | $441.0M−3% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $454.4M+1% | SEC ↗ |
| Q3 2024 | Oct 8, 2024 | $450.9M+5% | SEC ↗ |
| Q2 2024 | Jul 15, 2024 | $430.1M+1% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $426.7M+8% | SEC ↗ |
| Q4 2023 | Jan 9, 2024 | $396.1M+12% | SEC ↗ |
| Q3 2023 | Oct 11, 2023 | $354.4M+1% | SEC ↗ |
| Q2 2023 | Jul 14, 2023 | $352.1M+5% | SEC ↗ |
| Q1 2023 | Apr 13, 2023 | $333.8M+7% | SEC ↗ |
| Q4 2022 | Jan 18, 2023 | $312.8M+20% | SEC ↗ |
| Q3 2022 | Oct 7, 2022 | $260.9M−5% | SEC ↗ |
| Q2 2022 | Jul 8, 2022 | $274.7M−15% | SEC ↗ |
| Q1 2022 | Apr 15, 2022 | $322.1M−6% | SEC ↗ |
| Q4 2021 | Jan 13, 2022 | $341.1M+7% | SEC ↗ |
| Q3 2021 | Oct 13, 2021 | $319.7M−2% | SEC ↗ |
| Q2 2021 | Jul 14, 2021 | $324.9M+8% | SEC ↗ |
| Q1 2021 | Apr 13, 2021 | $300.0M+2% | SEC ↗ |
| Q4 2020 | Jan 12, 2021 | $293.0M+17% | SEC ↗ |
| Q3 2020 | Oct 13, 2020 | $250.5M+3% | SEC ↗ |
| Q2 2020 | Jul 13, 2020 | $243.1M+24% | SEC ↗ |
| Q1 2020 | Apr 10, 2020 | $196.4M−20% | SEC ↗ |
| Q4 2019 | Jan 9, 2020 | $244.1M+8% | SEC ↗ |
| Q3 2019 | Oct 11, 2019 | $225.8M+3% | SEC ↗ |
| Q2 2019 | Jul 10, 2019 | $220.1M+2% | SEC ↗ |
| Q1 2019 | Apr 8, 2019 | $215.0M+13% | SEC ↗ |
| Q4 2018 | Jan 15, 2019 | $191.0M−11% | SEC ↗ |
| Q3 2018 | Oct 15, 2018 | $215.4M+6% | SEC ↗ |
| Q2 2018 | Jul 17, 2018 | $202.3M+0% | SEC ↗ |
| Q1 2018 | Apr 16, 2018 | $201.4M+1% | SEC ↗ |
| Q4 2017 | Jan 12, 2018 | $200.2M+4% | SEC ↗ |
| Q3 2017 | Oct 13, 2017 | $192.6M+4% | SEC ↗ |
| Q2 2017 | Jul 10, 2017 | $185.8M+9% | SEC ↗ |
| Q1 2017 | Apr 11, 2017 | $170.1M+3% | SEC ↗ |
| Q4 2016 | Jan 10, 2017 | $164.8M+5% | SEC ↗ |
| Q3 2016 | Oct 11, 2016 | $157.7M+4% | SEC ↗ |
| Q2 2016 | Jul 8, 2016 | $151.6M+3% | SEC ↗ |
| Q1 2016 | Apr 15, 2016 | $147.0M | SEC ↗ |